HYLA3D hylauronic acid activating complex
The present invention provides cosmetic formulations for improving the appearance of the skin, including the facial area. The compositions of the invention provide multiple enhanced technologies that work synergistically to enhance hydration and appearance of the skin. Anti-aging peptides and tissue respiratory factor work together in an HA rich environment to enhance collagen and elastin while beneficial antioxidants protect HA in the skin from damaging exposure.
1. A cosmetic composition for topical application to improve appearance of skin comprising:
a blend of hyaluronate forms comprising:
0.5% to 5% by weight encapsulated sodium hyaluronate; 0.25% to 3% by weight sodium hyaluronate crosspolymer; 0.25% to 3% by weight ultra low molecular weight sodium hyaluronate; and 0.0025% to 0.05% by weight high molecular weight sodium hyaluronate; and
a cosmetically acceptable vehicle.
2. The composition of claim 1 , further comprising a blend of activating ingredients comprising:
0.25% to 5% by weight dermal respiratory factor formulation; 0.1% to 2% by weight calcium ketogluconate; 0.5% to 2% by weight ubiquinone; and 0.00025%-0.01% by weight oligopeptide-24.
3. The composition of claim 1 wherein the blend of hyaluronate forms comprises:
1% to 3% by weight encapsulated sodium hyaluronate; 0.5% to 2% by weight sodium hyaluronate crosspolymer; 0.5% to 2% by weight ultra low molecular weight sodium hyaluronate; and 0.005% to 0.05% by weight high molecular weight sodium hyaluronate.
4. The composition of claim 3 , wherein the blend of activating ingredients comprises:
0.5% to 3% by weight dermal respiratory factor formulation; 0.25% to 1% by weight calcium ketogluconate; 0.1% to 1% by weight ubiquinone; and 0.0005%-0.005% by weight oligopeptide-24.
5. The composition of claim 4 , wherein the ubiquinone is provided in a phospholipid emulsion.
6. The composition of claim 4 , formulated as a serum or gel.
7. A method of improving the appearance of the skin, comprising:
topically applying a cosmetic formulation comprising a blend of hyaluronate forms comprising:
0.5% to 5% by weight encapsulated sodium hyaluronate; 0.25% to 3% by weight sodium hyaluronate crosspolymer; 0.25% to 3% by weight ultra low molecular weight sodium hyaluronate; and 0.0025% to 0.05% by weight high molecular weight sodium hyaluronate; and
a cosmetically acceptable vehicle.
8. The method of claim 7 , wherein the cosmetic formulation further comprises:
a blend of activating ingredients comprising:
0.25% to 5% by weight dermal respiratory factor formulation; 0.1% to 2% by weight calcium ketogluconate; 0.5% to 2% by weight ubiquinone; and 0.00025%-0.01% by weight oligopeptide-24.
9. The method of claim 7 , wherein the blend of hyaluronate forms comprises:
1% to 3% by weight encapsulated sodium hyaluronate; 0.5% to 2% by weight sodium hyaluronate crosspolymer; 0.5% to 2% by weight ultra low molecular weight sodium hyaluronate; and 0.005% to 0.05% by weight high molecular weight sodium hyaluronate.
10. The method of claim 8 , wherein the blend of activating ingredients comprises:
0.5% to 3% by weight dermal respiratory factor formulation; 0.25% to 1% by weight calcium ketogluconate; 0.1% to 1% by weight ubiquinone; and 0.0005%-0.005% by weight oligopeptide 24.
11. The method of claim 10 , wherein the ubiquinone is provided in a phospholipid emulsion.
12. The method of claim 10 , wherein the cosmetic formulation is a serum or gel.